Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $60.9 million.

  • Avadel Pharmaceuticals' Shares Outstanding rose 387.1% to $60.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $60.9 million, marking a year-over-year increase of 387.1%. This contributed to the annual value of $58.6 million for FY2021, which is 38.36% up from last year.
  • As of Q3 2022, Avadel Pharmaceuticals' Shares Outstanding stood at $60.9 million, which was up 387.1% from $59.0 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Shares Outstanding high stood at $63.5 million for Q2 2020, and its period low was $42.1 million during Q1 2018.
  • Moreover, its 5-year median value for Shares Outstanding was $58.2 million (2020), whereas its average is $51.9 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 4857.94% in 2020, then crashed by 794.66% in 2021.
  • Avadel Pharmaceuticals' Shares Outstanding (Quarter) stood at $42.7 million in 2018, then increased by 0.48% to $42.9 million in 2019, then surged by 36.04% to $58.4 million in 2020, then rose by 0.38% to $58.6 million in 2021, then increased by 3.86% to $60.9 million in 2022.
  • Its last three reported values are $60.9 million in Q3 2022, $59.0 million for Q2 2022, and $59.0 million during Q1 2022.